Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy.
纤溶酶原激活物抑制剂 1 与高级别浆液性卵巢癌转移相关，并且在接受新辅助化疗的患者中减少
期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2023.1150991
Kelly Tanya E, Spillane Cathy L, Ward Mark P, Hokamp Karsten, Huang Yanmei, Tewari Prerna, Martin Cara M, Norris Lucy A, Mohamed Bashir M, Bates Mark, Brooks Robert, Selemidis Stavros, Brooks Douglas A, Kamran Waseem, Saadeh Feras Abu, O'Toole Sharon A, O'Leary John J
